Meg Doherty
ON THE RECORD · 5 verbatim quotes · every quote source-verified
“These new recommendations are designed for real-world use. WHO is working closely with countries and partners to support the implementation,”
Meg Doherty · said date not stated · reported 2025-07-14
The WHO recommended that countries include the newly approved HIV drug lenacapavir in their prevention efforts.
“WHO is providing technical assistance to countries interested in adopting LEN and simplified testing strategies, in coordination with global partners like the Global Fund, UNAIDS and several other partners and donors,”
Meg Doherty · said date not stated · reported 2025-07-14
Dr. Doherty explained that the WHO is providing technical assistance to countries seeking to adopt lenacapavir.
“We call on governments, funders, implementers and civil society to work together for implementing and integrating LEN into the HIV programs. And we believe time to act is now.”
Meg Doherty · said date not stated · reported 2025-07-14
Dr. Doherty called on governments and donors to collaborate on integrating lenacapavir into HIV programs.
“LEN is a six-monthly injectable option, and it may be particularly attractive for people who prefer fewer clinic visits or have challenges with daily oral PrEP. … It could improve adherence and reach more people who need HIV prevention and can be used in pregnant and breastfeeding women,”
Meg Doherty · said date not stated · reported 2025-07-14
Dr. Doherty noted the advantages of a six-monthly injectable HIV prevention option over daily oral PrEP.
“The first recommendation is that a long-acting injectable, lenacapavir, should be offered as an additional prevention choice for people at risk for HIV and as part of combination prevention. With that, we call it a strong recommendation with moderate to high certainty of the evidence,”
Meg Doherty · said date not stated · reported 2025-07-14
The WHO issued recommendations regarding the use of injectable lenacapavir for HIV prevention.